BioTek receives patent for imaging and microplate reading used in Cytation Cell Imaging Multi-Mode readers

BioTek has been granted US patent 9,557,217 for imaging and microplate reading in one instrument.  The intellectual property protected by this patent is used in BioTek’s award winning line of Cytation™ Cell Imaging Multi-Mode readers. Other patents are pending.

Cytation offers fluorescence, brightfield, color brightfield and phase contrast imaging up to 60x, and multi-mode detection optics that include fluorescence intensity, luminescence, absorbance and advanced measurements such as fluorescence polarization, time-resolved fluorescence and AlphaScreen®. Cytation systems are ideally suited to live cell assays, with incubation to 65 °C, shaking, plus available CO2/O2 control. Gen5™ Microplate Reader and Imager Software controls all imaging and multi-mode instrument operations, and provides quantitative and qualitative image and data analysis for a wide range of applications including cell migration, label-free cell counting, phenotypic analysis, DNA/RNA quantification or ROS assays.

AlphaScreen is a registered trademark of PerkinElmer, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
CAR T-cell therapy in colorectal cancer